Cannabidiol (CBD) is one of the many cannabinoid compounds present in the cannabis plant. It is classified as non-intoxicating, meaning it is not associated with the altered mental state linked to tetrahydrocannabinol. CBD interacts with the endocannabinoid system, although its mechanisms are described as more complex and less directly receptor-binding than those of THC.
In Australia, the regulatory status of cannabidiol depends on factors such as concentration, formulation and intended use. Certain low-dose preparations have been considered for down-scheduling, while most therapeutic CBD products remain prescription-only and are subject to oversight by the Therapeutic Goods Administration.
Cannabidiol continues to be researched across a range of fields. Within an educational context it is best understood as a defined chemical entity with a specific classification and regulatory pathway, rather than as a finished product.